Loading...
XWAR
PPS
Market cap23mUSD
Dec 05, Last price  
0.93PLN
1D
-1.07%
1Q
1.09%
Jan 2017
-11.06%
Name

Przedsiebiorstwo Przemyslu Spozywczego PEPEES SA

Chart & Performance

D1W1MN
XWAR:PPS chart
P/E
P/S
0.37
EPS
Div Yield, %
Shrs. gr., 5y
-0.25%
Rev. gr., 5y
0.35%
Revenues
236m
+6.22%
92,569,00088,287,00077,319,00081,427,000128,112,000119,549,000116,496,000141,553,000185,675,000224,273,000239,941,000231,981,000204,079,000220,826,000254,952,000222,218,000236,049,000
Net income
-15m
L
-1,825,000-9,442,0001,773,0008,572,0001,895,000654,0003,373,0005,288,00017,600,00013,364,00023,091,00024,091,0006,313,000-3,206,00010,595,0003,999,000-14,701,000
CFO
9m
-50.59%
-21,951,00012,100,00018,431,000-15,169,00010,445,00010,927,000-22,901,0007,229,00014,080,00020,465,00030,474,00036,688,000-118,00019,057,00028,166,00018,054,0008,920,000
Dividend
Jun 05, 20230.1 PLN/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Pepees S.A. engages in the potatoes processing business in Poland and internationally. It offers potato starch, a substance used in the meat, food concentrate, baking, textile, paper, chemical, and cosmetic and pharmaceutical industries; and maltodextrin, a starch substance for use in the production of baby nutrition products, nutrition and energizing drinks, medical substances, frozen foods, and foodstuff products, as well as in the confectionary and meat industries. The company also provides crystalline glucose used in the pharmaceutical, foodstuff, and chemical industries; and for direct consumption, as well as a sweetener. In addition, it offers anhydrous glucose for producing drugs and supplements; glucose syrups for use in confectionary industry; and feedstuff potato protein, a component of feedstuff mixes for animals. Pepees S.A. is based in Lomza, Poland.
IPO date
May 22, 1997
Employees
414
Domiciled in
PL
Incorporated in
PL

Valuation

Title
PLN in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT